Instrument Inactif

Autres langues Novavax, Inc. Nasdaq

Actions

US6700021040

Autres langues

Novavax Seeks Health Canada Approval for Updated Covid-19 Vaccine	02/07
Novavax : sollicité Santé Canada pour son vaccin Covid 24/25	02/07
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine	02/07
Novavax - U.S. CDC and ACIP Recommend Use of Authorized and Approved 2024-2025 COVID-19 Vaccines	28/06
Novavax : l'ACIP en faveur de vaccin Covid 24/25	28/06
Novavax : U.S. ACIP Recommends Use of Authorized and Approved 2024 2025 COVID 19 Vaccines	27/06
US CDC advisers recommend updated COVID vaccines for those six months and older	27/06
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Rises in After-Hours Trading Following Major UK Contracts and FDA Progress	27/06
Novavax : sollicite l'EMA pour son vaccin Covid dès 12 ans	24/06
Novavax Seeks EU Authorization for Updated Covid-19 Vaccine	24/06
Novavax Submits Application to European Medicines Agency for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine	24/06
Peraso Inc. (NASDAQ: PRSO) Director Invests $127K, Ladenburg Thalmann Coverage, Gains Bullish Momentum	20/06
Catheter Precision (NYSE American: VTAK) Announces New LockeT Purchase Order and Expands Sales Team Amid Surge in Trading Volume	19/06
Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine	17/06
Novavax Files Emergency Use Authorization Amendment For Updated COVID-19 Vaccine	14/06
FDA asks COVID vaccine makers to target KP.2 strain with updated shots	14/06
Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine	14/06
Novavax, Inc. Submits Application to U.S. FDA for Updated Protein-Based 2024-2025 Formula COVID-19 Vaccine	14/06
COVID shots should target JN.1 variants in 2024-25 campaign, US FDA says	07/06
S&P 500, Nasdaq dip on the eve of US payrolls data	06/06

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

Novavax bondit suite à l'accord de 1,2 milliard de dollars avec Sanofi pour un vaccin

Le 10 mai 2024 à 20:52